Clinical Trial Update: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2 [Phase 2]

View source ↗

Summary

A Phase 2 sub-study of a platform trial comparing novel regimens against standard of care in non-small cell lung cancer was terminated, with results posted on 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2025-06-04